Pharmacologic Treatments for COVID-19

The pandemic of coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses an unprecedented challenge in terms of identifying effective prevention and treatment medications. Although some clinical research on traditional antiviral medicines have been undertaken around the world, the outcomes are still inconclusive. In general, the optimal treatment for COVID-19 patients is determined by a number of characteristics, including the disease's stage and symptoms. Administration of drugs among different patient populations may be difficult due to variances in individual genetics in drug metabolism as well as the diversity of immune responses to the coronavirus.